Ph2 open label study to evaluate the cytokine in combo with subjects w/Large B-Cell Lymph
Phase II Clinical Trial
A PHASE II OPEN-LABEL MULTICENTER STUDY TO EVALUATE THE OPTIMIZATION OF THE CYTOKINE RELEASE SYNDROME PROFILE FOR GLOFITAMAB IN COMBINATION WITH GEMCITABINE PLUS OXALIPLATIN IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMA (GO45434)
Participating Locations